AAAAAA

   
Results: 1-25 | 26-31
Results: 1-25/31
Targeting gene therapy to the tumor vasculature
Authors: Lau, KKW Bicknell, R
Citation: Kkw. Lau et R. Bicknell, Targeting gene therapy to the tumor vasculature, NEW ANGIOTHERAPY, 2002, pp. 453-473
Hypoxia and oxidative stress in breast cancer - Oxidative stress: its effects on the growth, metastatic potential and response to therapy of breast cancer
Authors: Brown, NS Bicknell, R
Citation: Ns. Brown et R. Bicknell, Hypoxia and oxidative stress in breast cancer - Oxidative stress: its effects on the growth, metastatic potential and response to therapy of breast cancer, BREAST CA R, 3(5), 2001, pp. 323-327
Differential and cell-specific expression of calcitonin receptor-like receptor and receptor activity modifying proteins in the human uterus
Authors: Nikitenko, LL Brown, NS Smith, DM MacKenzie, IZ Bicknell, R Rees, MCP
Citation: Ll. Nikitenko et al., Differential and cell-specific expression of calcitonin receptor-like receptor and receptor activity modifying proteins in the human uterus, MOL HUM REP, 7(7), 2001, pp. 655-664
Vascular endothelial growth factor transgenic mice exhibit reduced male fertility and placental rejection (vol 7, pg 255, 2001)
Authors: Huminiecki, L Chan, HY Liu, S Poulsom, R Stamp, G Harris, AL Bicknell, R
Citation: L. Huminiecki et al., Vascular endothelial growth factor transgenic mice exhibit reduced male fertility and placental rejection (vol 7, pg 255, 2001), MOL HUM REP, 7(5), 2001, pp. 495-495
Vascular endothelial growth factor transgenic mice exhibit reduced male fertility and placental rejection
Authors: Huminiecki, L Chan, HY Lui, S Poulsom, R Stamp, G Harris, AL Bicknell, R
Citation: L. Huminiecki et al., Vascular endothelial growth factor transgenic mice exhibit reduced male fertility and placental rejection, MOL HUM REP, 7(3), 2001, pp. 255-264
Relation of vascular endothelial growth factor production to expression and regulation of hypoxia-inducible factor-1 alpha and hypoxia-inducible factor-2 alpha in human bladder tumors and cell lines
Authors: Jones, A Fujiyama, C Blanche, C Moore, JW Fuggle, S Cranston, D Bicknell, R Harris, AL
Citation: A. Jones et al., Relation of vascular endothelial growth factor production to expression and regulation of hypoxia-inducible factor-1 alpha and hypoxia-inducible factor-2 alpha in human bladder tumors and cell lines, CLIN CANC R, 7(5), 2001, pp. 1263-1272
Adrenomedullin inhibits hypoxic cell death by upregulation of Bcl-2 in endometrial cancer cells: a possible promotion mechanism for tumour growth
Authors: Oehler, MK Norbury, C Hague, S Rees, MCP Bicknell, R
Citation: Mk. Oehler et al., Adrenomedullin inhibits hypoxic cell death by upregulation of Bcl-2 in endometrial cancer cells: a possible promotion mechanism for tumour growth, ONCOGENE, 20(23), 2001, pp. 2937-2945
Mid-luteal angiogenesis and function in the primate is dependent on vascular endothelial growth factor
Authors: Dickson, SE Bicknell, R Fraser, HM
Citation: Se. Dickson et al., Mid-luteal angiogenesis and function in the primate is dependent on vascular endothelial growth factor, J ENDOCR, 168(3), 2001, pp. 409-416
Human bladder cancer invasion model using rat bladder in vitro and its useto test mechanisms and therapeutic inhibitors of invasion
Authors: Fujiyama, C Jones, A Fuggle, S Bicknell, R Cranston, D Harris, AL
Citation: C. Fujiyama et al., Human bladder cancer invasion model using rat bladder in vitro and its useto test mechanisms and therapeutic inhibitors of invasion, BR J CANC, 84(4), 2001, pp. 558-564
Therapeutic inhibition of angiogenesis
Authors: Zhang, HT Bicknell, R
Citation: Ht. Zhang et R. Bicknell, Therapeutic inhibition of angiogenesis, METH MOL M, 46, 2001, pp. 3-26
Angiogenesis and lymphangiogenesis in stage 1 germ cell tumours of the testis
Authors: Jones, A Fujiyama, C Turner, K Fuggle, S Cranston, D Turley, H Valtola, R Bicknell, R Harris, AL
Citation: A. Jones et al., Angiogenesis and lymphangiogenesis in stage 1 germ cell tumours of the testis, BJU INT, 86(1), 2000, pp. 80-86
Elevated serum vascular endothelial growth factor in patients with hormone-escaped prostate cancer
Authors: Jones, A Fujiyama, C Turner, K Fuggle, S Cranston, D Bicknell, R Harris, AL
Citation: A. Jones et al., Elevated serum vascular endothelial growth factor in patients with hormone-escaped prostate cancer, BJU INT, 85(3), 2000, pp. 276-280
Adrenomedullin is an autocrine regulator of endothelial growth in human endometrium
Authors: Nikitenko, LL MacKenzie, IZ Rees, MCP Bicknell, R
Citation: Ll. Nikitenko et al., Adrenomedullin is an autocrine regulator of endothelial growth in human endometrium, MOL HUM REP, 6(9), 2000, pp. 811-819
In silico cloning of novel endothelial-specific genes
Authors: Huminiecki, L Bicknell, R
Citation: L. Huminiecki et R. Bicknell, In silico cloning of novel endothelial-specific genes, GENOME RES, 10(11), 2000, pp. 1796-1806
Expression of the hypoxically regulated angiogenic factor adrenomedullin correlates with uterine leiomyoma vascular density
Authors: Hague, S Zhang, L Oehler, MK Manek, S MacKenzie, IZ Bicknell, R Rees, MCP
Citation: S. Hague et al., Expression of the hypoxically regulated angiogenic factor adrenomedullin correlates with uterine leiomyoma vascular density, CLIN CANC R, 6(7), 2000, pp. 2808-2814
Application of the enrichment approach to identify putative markers of response to 5-fluorouracil therapy in advanced colorectal carcinomas
Authors: McKay, JA Lloret, C Murray, GI Johnston, PG Bicknell, R Ahmed, FY Cassidy, J McLeod, HL
Citation: Ja. Mckay et al., Application of the enrichment approach to identify putative markers of response to 5-fluorouracil therapy in advanced colorectal carcinomas, INT J ONCOL, 17(1), 2000, pp. 153-158
Increasing endothelial cell specific expression by the use of heterologoushypoxic and cytokine-inducible enhancers
Authors: Modlich, U Pugh, CW Bicknell, R
Citation: U. Modlich et al., Increasing endothelial cell specific expression by the use of heterologoushypoxic and cytokine-inducible enhancers, GENE THER, 7(10), 2000, pp. 896-902
Steroids and the endometrium
Authors: Oehler, MK Rees, MCP Bicknell, R
Citation: Mk. Oehler et al., Steroids and the endometrium, CURR MED CH, 7(5), 2000, pp. 543-560
Recovery of a sexual and an apomictic hybrid from crosses between the facultative apomicts Hieracium caespitosum and H-praealtum
Authors: Chapman, H Bicknell, R
Citation: H. Chapman et R. Bicknell, Recovery of a sexual and an apomictic hybrid from crosses between the facultative apomicts Hieracium caespitosum and H-praealtum, NZ J ECOL, 24(1), 2000, pp. 81-85
Expression of angiogenic factor thymidine phosphorylase and angiogenesis in human atherosclerosis
Authors: Boyle, JJ Wilson, B Bicknell, R Harrower, S Weissberg, PL Fan, TP
Citation: Jj. Boyle et al., Expression of angiogenic factor thymidine phosphorylase and angiogenesis in human atherosclerosis, J PATHOLOGY, 192(2), 2000, pp. 234-242
Thymidine phosphorylase expression in normal and hyperplastic endometrium
Authors: Sivridis, E Giatromanolaki, A Koukourakis, MI Bicknell, R Harris, AL Gatter, KC
Citation: E. Sivridis et al., Thymidine phosphorylase expression in normal and hyperplastic endometrium, J CLIN PATH, 53(9), 2000, pp. 704-708
Suppression of luteal angiogenesis in the primate after neutralization of vascular endothelial growth factor
Authors: Fraser, HM Dickson, SE Lunn, SF Wulff, C Morris, KD Carroll, VA Bicknell, R
Citation: Hm. Fraser et al., Suppression of luteal angiogenesis in the primate after neutralization of vascular endothelial growth factor, ENDOCRINOL, 141(3), 2000, pp. 995-1000
Thymidine phosphorylase induces carcinoma cell oxidative stress and promotes secretion of angiogenic factors
Authors: Brown, NS Jones, A Fujiyama, C Harris, AL Bicknell, R
Citation: Ns. Brown et al., Thymidine phosphorylase induces carcinoma cell oxidative stress and promotes secretion of angiogenic factors, CANCER RES, 60(22), 2000, pp. 6298-6302
Vascular endothelial growth factor (VEGF) in breast cancer: Comparison of plasma, serum, and tissue VEGF and microvessel density and effects of tamoxifen
Authors: Adams, J Carder, PJ Downey, S Forbes, MA MacLennan, K Allgar, V Kaufman, S Hallam, S Bicknell, R Walker, JJ Cairnduff, F Selby, PJ Perren, TJ Lansdown, M Banks, RE
Citation: J. Adams et al., Vascular endothelial growth factor (VEGF) in breast cancer: Comparison of plasma, serum, and tissue VEGF and microvessel density and effects of tamoxifen, CANCER RES, 60(11), 2000, pp. 2898-2905
The 121 amino acid isoform of vascular endothelial growth factor is move strongly tumorigenic than other splice variants in vivo
Authors: Zhang, HT Scott, PAE Morbidelli, L Peak, S Moore, J Turley, H Harris, AL Ziche, M Bicknell, R
Citation: Ht. Zhang et al., The 121 amino acid isoform of vascular endothelial growth factor is move strongly tumorigenic than other splice variants in vivo, BR J CANC, 83(1), 2000, pp. 63-68
Risultati: 1-25 | 26-31